Home/ Supplements/ Electrolytes/ Maximum Strength Estroblend

Maximum Strength Estroblend

product on market Other (e.g. tea bag) Equate Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Black cohosh and soy isoflavones are commonly used to manage menopausal symptoms, though research evidence for their efficacy remains limited and mixed. Calcium supports bone health and is backed by strong evidence for maintaining skeletal density. The overall evidence coverage for this specific ingredient combination is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Maximum Strength Estroblend
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Caplet(s)
Serving Size
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s) (1% DV)
Calcium
90 mg (9% DV)
Market median: 80.0mg (136 products)
Market median: 60.0mg (94 products) 13 studies (A:0, B:7)
Balancing Herbal Blend
145 mg
52 mg
Market median: 180.0mg (239 products) 49 studies (A:1, B:19)

Other Ingredients

Dicalcium Phosphate Microcrystalline Cellulose Maltodextrin Crospovidone Croscarmellose Sodium Hypromellose Stearic Acid Silicon Dioxide Magnesium Stearate Titanium Dioxide Riboflavin Polyethylene Glycol Polysorbate 80
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

1 per day

Directions: Adults, take one (1) caplet per day with a meal. For best results, daily use is important.

Warnings & Precautions

Contains: Soy

Warning: Do not use if pregnant, considering becoming pregnant or nursing a baby. Consult your doctor prior to use if you have a liver disorder or develop symptoms of liver trouble such as abdominal pain, dark urine, or jaundice. If you are planning any medical procedure, have any other medical condition, including but not limited to: a hormone-sensitive condition or bleeding problems, or if you are taking any medication or other dietary supplements consult a doctor before use.

Some consumers may experience gastrointestinal discomfort, but it should not be persistent. Discontinue use and see if any other side effects occur. This product is not intended/recommended for children under 18 years of age and those sensitive to caffeine.

This product is not intended/recommended for children under 18 years of age and those sensitive to caffeine. Keep out of reach of children.

Formulation Notes

Compare to Estroven Maximum Strength Multi-Symptom Menopause Formula Helps reduce hot flashes and night sweats Helps manage irritability and occasional fatigue

Contains: Soy

This product contains about as much caffeine (55 mg/serving) as about one half cup of coffee.

This product contains 80 mg of Black Cohosh per serving as compared to a multi-ingredient menopause supplement that contains 40 mg of Black Cohosh per serving.

Additional Information

This product is not manufactured or distributed by i-Health, Inc., distributor of Estroven Maximum Strength

Store at room temperature (59 degrees-86 degrees F). Do not expose to excessive heat, humidity, or direct sunlight.

Metadata

Product Details

DSLD Entry Date2020-01-25
Product TypeOther Combinations
FormOther (e.g. tea bag)
BrandEquate
DSLD ID211452
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.